LBO — NOLAND HOSPITAL TUSCALOOSA II
IRR: 16.8% | MOIC: 2.17x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.8%
IRR
2.17x
MOIC
$6.8M
Entry EV
$10.3M
Exit EV
$3.5M
Equity Invested
Sources & Uses
S&UTotal · $6.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $2.6M | 38.8% | |
| Sub Debt | $0.7M | 9.7% | |
| Equity | $3.5M | 51.5% | |
| Enterprise Value | $6.6M | 97.1% | |
| Transaction Fees | $0.2M | 2.9% | |
| Total Uses | $6.8M | 100.0% |
Interpretation
INTAt 2.17x MOIC and 16.8% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $1.0M |
| Exit Ev | $10.3M |
| Net Debt At Exit | $2.7M |
| Equity At Exit | $7.6M |
| Equity Invested | $3.5M |
| Total Value Created | $4.1M |
| Value From Growth | $3.4M |
| Value From Multiple | $0.3M |
| Value From Deleveraging | $0.6M |